Skip to main content
Erschienen in: World Journal of Urology 8/2020

07.11.2018 | Original Article

Bladder and ureteral injuries during benign hysterectomy: an observational cohort analysis in New York State

verfasst von: Cooper R. Benson, Stephanie Thompson, Gen Li, Denise Asafu-Adjei, Steven B. Brandes

Erschienen in: World Journal of Urology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hysterectomy (Hys) is the most common non-urologic surgery associated with iatrogenic genitourinary (GU) injury. We present the largest known population-based evaluation of GU injury related to benign Hys.

Methods

The New York Statewide Planning and Research Cooperative System (SPARCS) was queried by ICD-9 and CPT codes. SPARCS for women from 1995 to 2014, who underwent laparoscopic or robotic Hys (minimally invasive surgery = MIS), abdominal Hys (AH), and vaginal Hys (VH) for benign diagnoses. Bladder and ureteral repairs were captured based on the procedure codes. Codes for ureteroneocystotomy (UNC) were compared to any other ureteral repairs, to elucidate injury patterns. Statistical analysis was conducted using Chi squared test, ANOVA, Mann–Whitney test and Poisson Regression and multivariable analysis were performed.

Results

516,340 women underwent Hys for a benign etiology. 69% were AH, 25% VH, and 6% were MIS. 7490 patients (1.45%) had a concomitant GU injury. Compared to VH, MIS and AH were associated with greater odds of bladder and ureteral injury (p < 0.001). MIS and AH, compared to VH, were associated with reduced odds of UNC compared to complex reconstruction (OR 0.27, p < 0.001 and OR 0.12, p < 0.00, respectively). The injured cohort had higher total mean charges ($29,889 vs $15,808) and length of hospitalization (6.32 vs 3.56 days) (p < 0.001).

Conclusions

Bladder and ureteral injuries during hysterectomy are uncommon in contemporary practice and are lower than historical rates. GU injury increases hospitalization cost. VH is associated with the lowest rate of GU injury, and thus appears to be a valuable approach, when feasible.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat LR SRAD (2012) Upper urinary tract trauma, in campbell-walsh urology. In: Wein AJ (Ed). Elsevier, p. 1169–1189 LR SRAD (2012) Upper urinary tract trauma, in campbell-walsh urology. In: Wein AJ (Ed). Elsevier, p. 1169–1189
2.
Zurück zum Zitat Cordon BH, Fracchia JA, Armenakas NA (2014) Iatrogenic nonendoscopic bladder injuries over 24 years: 127 cases at a single institution. Urology 84(1):222–226PubMedCrossRef Cordon BH, Fracchia JA, Armenakas NA (2014) Iatrogenic nonendoscopic bladder injuries over 24 years: 127 cases at a single institution. Urology 84(1):222–226PubMedCrossRef
3.
Zurück zum Zitat Cohen AJ et al (2016) Iatrogenic bladder injury: national analysis of 30-day outcomes. Urology 97:250–256PubMedCrossRef Cohen AJ et al (2016) Iatrogenic bladder injury: national analysis of 30-day outcomes. Urology 97:250–256PubMedCrossRef
4.
Zurück zum Zitat Sharp HT, Adelman MR (2016) Prevention, recognition, and management of urologic injuries during gynecologic surgery. Obstet Gynecol 127(6):1085–1096PubMedCrossRef Sharp HT, Adelman MR (2016) Prevention, recognition, and management of urologic injuries during gynecologic surgery. Obstet Gynecol 127(6):1085–1096PubMedCrossRef
5.
Zurück zum Zitat Ibeanu OA et al (2009) Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol 113(1):6–10PubMedCrossRef Ibeanu OA et al (2009) Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol 113(1):6–10PubMedCrossRef
6.
Zurück zum Zitat Schimpf MO, Gottenger EE, Wagner JR (2008) Universal ureteral stent placement at hysterectomy to identify ureteral injury: a decision analysis. BJOG 115(9):1151–1158PubMedCrossRef Schimpf MO, Gottenger EE, Wagner JR (2008) Universal ureteral stent placement at hysterectomy to identify ureteral injury: a decision analysis. BJOG 115(9):1151–1158PubMedCrossRef
8.
Zurück zum Zitat Teeluckdharry B, Gilmour D, Flowerdew G (2015) Urinary tract injury at benign gynecologic surgery and the role of cystoscopy: a systematic review and meta-analysis. Obstet Gynecol 126(6):1161–1169PubMedCrossRef Teeluckdharry B, Gilmour D, Flowerdew G (2015) Urinary tract injury at benign gynecologic surgery and the role of cystoscopy: a systematic review and meta-analysis. Obstet Gynecol 126(6):1161–1169PubMedCrossRef
9.
Zurück zum Zitat Gilmour DT, Baskett TF (2005) Disability and litigation from urinary tract injuries at benign gynecologic surgery in Canada. Obstet Gynecol 105(1):109–114PubMedCrossRef Gilmour DT, Baskett TF (2005) Disability and litigation from urinary tract injuries at benign gynecologic surgery in Canada. Obstet Gynecol 105(1):109–114PubMedCrossRef
10.
Zurück zum Zitat Petersen SS et al (2018) Rate of urologic injury with robotic hysterectomy. J Minim Invasive Gynecol 25(5):867–871PubMedCrossRef Petersen SS et al (2018) Rate of urologic injury with robotic hysterectomy. J Minim Invasive Gynecol 25(5):867–871PubMedCrossRef
11.
Zurück zum Zitat Packiam VT et al (2016) The impact of minimally invasive surgery on major iatrogenic ureteral injury and subsequent ureteral repair during hysterectomy: a national analysis of risk factors and outcomes. Urology 98:183–188PubMedCrossRef Packiam VT et al (2016) The impact of minimally invasive surgery on major iatrogenic ureteral injury and subsequent ureteral repair during hysterectomy: a national analysis of risk factors and outcomes. Urology 98:183–188PubMedCrossRef
12.
Zurück zum Zitat Wallis CJ et al (2016) Occurrence of and risk factors for urological intervention during benign hysterectomy: analysis of the national surgical quality improvement program database. Urology 97:66–72PubMedCrossRef Wallis CJ et al (2016) Occurrence of and risk factors for urological intervention during benign hysterectomy: analysis of the national surgical quality improvement program database. Urology 97:66–72PubMedCrossRef
14.
Zurück zum Zitat Pitter MC et al (2014) The impact of different surgical modalities for hysterectomy on satisfaction and patient reported outcomes. Interact J Med Res 3(3):e11PubMedPubMedCentralCrossRef Pitter MC et al (2014) The impact of different surgical modalities for hysterectomy on satisfaction and patient reported outcomes. Interact J Med Res 3(3):e11PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat ACOG Committee Opinion. Number 372. July 2007 (2007) The Role of cystourethroscopy in the generalist obstetrician-gynecologist practice. Obstet Gynecol 110(1):221–224CrossRef ACOG Committee Opinion. Number 372. July 2007 (2007) The Role of cystourethroscopy in the generalist obstetrician-gynecologist practice. Obstet Gynecol 110(1):221–224CrossRef
16.
Zurück zum Zitat Aarts JW et al (2015) Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 12(8):1–132 Aarts JW et al (2015) Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 12(8):1–132
17.
Zurück zum Zitat David-Montefiore E et al (2007) Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod 22(1):260–265PubMedCrossRef David-Montefiore E et al (2007) Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod 22(1):260–265PubMedCrossRef
18.
Zurück zum Zitat Wong JMK et al (2018) Urinary tract injury in gynecologic laparoscopy for benign indication: a systematic review. Obstet Gynecol 131(1):100–108PubMedCrossRef Wong JMK et al (2018) Urinary tract injury in gynecologic laparoscopy for benign indication: a systematic review. Obstet Gynecol 131(1):100–108PubMedCrossRef
19.
Zurück zum Zitat Mamik MM et al (2014) Risk factors for lower urinary tract injury at the time of hysterectomy for benign reasons. Int Urogynecol J 25(8):1031–1036PubMedPubMedCentralCrossRef Mamik MM et al (2014) Risk factors for lower urinary tract injury at the time of hysterectomy for benign reasons. Int Urogynecol J 25(8):1031–1036PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Schiavone MB et al (2012) The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals. Am J Obstet Gynecol 207(3):174.e1–174.e7CrossRef Schiavone MB et al (2012) The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals. Am J Obstet Gynecol 207(3):174.e1–174.e7CrossRef
21.
Zurück zum Zitat Satitniramai S, Manonai J (2017) Urologic injuries during gynecologic surgery, a 10-year review. J Obstet Gynaecol Res 43(3):557–563PubMedCrossRef Satitniramai S, Manonai J (2017) Urologic injuries during gynecologic surgery, a 10-year review. J Obstet Gynaecol Res 43(3):557–563PubMedCrossRef
22.
Zurück zum Zitat Anand M et al (2015) Utility of intraoperative cystoscopy in detecting ureteral injury during vaginal hysterectomy. Female Pelvic Med Reconstr Surg 21(2):70–76PubMedCrossRef Anand M et al (2015) Utility of intraoperative cystoscopy in detecting ureteral injury during vaginal hysterectomy. Female Pelvic Med Reconstr Surg 21(2):70–76PubMedCrossRef
23.
Zurück zum Zitat Committee Opinion No 701 (2017) Choosing the route of hysterectomy for benign disease. Obstet Gynecol 129(6):e155–e159CrossRef Committee Opinion No 701 (2017) Choosing the route of hysterectomy for benign disease. Obstet Gynecol 129(6):e155–e159CrossRef
Metadaten
Titel
Bladder and ureteral injuries during benign hysterectomy: an observational cohort analysis in New York State
verfasst von
Cooper R. Benson
Stephanie Thompson
Gen Li
Denise Asafu-Adjei
Steven B. Brandes
Publikationsdatum
07.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2541-y

Weitere Artikel der Ausgabe 8/2020

World Journal of Urology 8/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.